2009 Year in Review
Happy New Year! With all twelve months of 2009 behind us and the exciting potential of 2010 ahead, our dLife Viewpoints columnists and Blogabetes bloggers have offered up their thoughts on and memories of 2009.
"This past year showed the online voices of diabetes communities in full bloom, with support and inspiration only a mouse-click away. And 2009 was the year that pharma made the leap to become part of the online communities, adding their voices to the thousands of people with diabetes they were trying to reach. For me personally, it's been a year of tremendous growth (both emotionally and physically, with my first baby due in the beginning of 2010), and I'm excited to see where the next 12 months take us all."
- Viewpoints Columnist Kerri Sparling, Generation D
"There were many exciting medical and technological changes in 2009. Some to note are:
Important studies for patients
- Exenatide OW better than Lantus
- Byetta approved for standalone use (see diatribe)
- Onglyza (EU + US)
- Obesity drugs (Vivus, Arena, Orexigen)
- Liraglutide approval in Europe
- Medtronic Veo
- Smith (maker of Deltec Cozmo pump) exits market
- Medingo Solo MicroPump Soon to Be on Insulin Pump Market
- Animas 2020 pump
- Expert Columnist Kelly Close, Close Concerns
"In 2008 adoption of social media among people touched by diabetes started taking off. In 2009, we saw an explosion! There were many more groups coming online and many more patients coming out of the 'diabetes closet' and joining social networks, tweeting about diabetes and making videos to help making sense of diabetes. We didn't focus on getting a World Diabetes Day doodle. Instead we turned to the diabetic community to get thousands of people participate in The Big Blue Test, turning it into the most successful viral initiative ever in diabetes. In 2010, we will continue to raise diabetes awareness and connect people touched by diabetes, while we wait for a cure."
- Viewpoints Columnist Manny Hernandez, Hola Diabetes
One in Ten AMI Patients Have Unrecognized Incident Diabetes
Two New LDL Cholesterol Drugs May Have Big Impact on Heart Disease
COBA Conference Steers Forward in the Fight Against Childhood Obesity
Google Secures Patent for Glucose-Sensing Contact Lens
Medtronic to Use GlucoSitter Artificial Pancreas Software in Future Insulin Pumps - A Big Deal!
Mushroom Stuffed Sole Baked Grits Wedges Cucumbers and Dip Roasted Striped Bass Cranberry Pork Chops Slow-Cook Chicken Breasts in Brandy Sauce Orange Scallops with Spinach and Walnuts Grilled Shrimp, White Bean, & Arugula Salad Goat Cheese & Pecan Spinach Salad Rice Patties
My diabetes is changing. Until a few years ago, my morning readings were reasonable and within the desired range of under 100 mg/dl. About two years ago, they started slipping upwards into the less-desirable but apparently not-worrisome range of 100-110 mg/dl. Now, this was what was recorded by my Abbott Freestyle Lite meter, which is known to record at the lower end of the home-glucometer variability range, but with my A1c firmly in the high 5s and low 6s, the meter's tendency to...